Effect of Propofol on Sevoflurane-Induced Myocardial Preconditioning in the Experiment
https://doi.org/10.15360/1813-9779-2013-4-30
Abstract
Objective: to estimate the magnitude of the cardioprotective properties of sevoflurane and propofol, when they are used alone and in combination in the acute experiment on rats after total ischemia/reperfusion (I/R). Materials and methods. The investigation was conducted on 50 male albino outbred rats weighing 202±19 g (M±ff), by using a total I/R model. The animals were randomized into 5 groups: 1) intraperitoneal chloral hydrate 300 mg/kg; 15-minute mechanical ventilation (MV); 2) inhalation induction with sevoflurane in an exsiccator; MV; injection of about 2—2.5 MAC sevoflurane in the expiratory breathing circuit for 15 minutes — anesthetic preconditioning simulation (APS); 3) anesthesia and APS with sevoflurane; then 10-minute ischemia simulation, followed by resuscitation and 5-minute reperfusion; 4) chloral hydrate anesthesia; injection of propofol 2.5 mg/kg in the right internal jugular vein; APS simulation; 5) chloral hydrate anesthesia; injection of propofol 2.5 mg/kg in the right internal jugular vein; and simulation of APS with sevoflurane. The hearts were extracted from all the animals and homogenized for further examination. The concentrations of total and phosphorylated glycogen synthase kinase-3/8 (GSK-3/8 and pGSK-3/8, respectively) were estimated by Western blotting. Results. The concentration of total GSK-3/8 was comparable in the groups. Group 2 showed a 1.5-fold increase in pGSK-3^ concentrations (p<0.05), a more increment (by more than twice) was observed in Group 3 (p<0.05). The concentration of pGSK-30 rose slightly in Group 4. In Group 5, the level of pGSK-30 decreased approximately twice that in Group 1 (p<0.05). Conclusion. Sevoflurane can be expected to have cardioprotective properties manifested as a considerably elevated p-GSK-Эв level. Propofol fails to exert a significant cardioprotective effect and when it is used in combination with sevoflurane, the latter is likely to completely deprive of the cardioprotective properties, by lowering the level of p-GSK-3^ below the reference values, which may be associated with the antioxidant properties of propofol. Evidently, further investigation should be continued to form ischemia/reperfusion groups when these anesthetics are co-administered. Key words: anesthetic preconditioning, sevorane, glycogen synthase kinase-3/3, Western blotting.
About the Authors
K. Yu BorisovV. V. Moroz
O. A. Grebenchikov
E. Yu, Plotnikov
D. I. Levikov
R. A. Cherpakov
V. V. Likhvantsev
References
1. Takahata O., Ichihara K., Ogawa H.Acta Anaesthesiol. Scand.
2. Warltier D.C., Pagel P.S., Kersten J.R.Approaches to the prevention of perioperative myocardial ischemia.Anesthesiology.2000; 92 (1): 253— 259.
3. Schlack W., Hollmann M., Stunneck J., Thamer V.Effect of halothane on myocardial reoxygenation injury in the isolated rat heart.Br. J. Anaesth.1996; 76 (6): 860—867.
4. De Hert S.G., Turani F., Mathur S., Stowe D.F.Cardioprotection with volatile anesthetics: mechanisms and clinical implications.Anesth. Analg.2005; 100 (6): 1584—1593.
5. Cason BA., Gamperl A.K., Slocum R.E., Hickey R.F.Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocar-dial infarct size in rabbits.Anesthesiology.1997; 87 (5): 1182—1190.
6. Tomai F., De Paulis R., Penta de Peppo A., Colagrande L., Caprara E., Polisca P., De Matteis G., Ghini A.S., Forlani S., Colella D., Chiariello L.Beneficial impact of isoflurane during coronary bypass surgery on tro-ponin I release.G. Ital. Cardiol.1999; 29 (9): 1007—1014.
7. De Hert S., Vlasselaers D., Barbe R., Ory J.P., Dekegel D., Donnadonni R., Demeere J.L., Mulier J., Wouters P.A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery.Anaesthesia.2009; 64 (9): 953—960.
8. De Hert S.G., Longrois D., Yang H., Fleisher LA.Does the use of a volatile anesthetic regimen attenuate the incidence of cardiac events after vascular surgery?Acta Anaesthesiol. Belg.2008; 59 (1): 19—25.
9. ЛихванцевВ.В., МорозВ.В., ГребенниковО.А., ГороховатскийЮ.И., ЗаржецкийЮ.В., ТимошинС.С., ЛевиковД.И., ШайбаковаВЛ.Ише-мическое и фармакологическое прекондиционирование.Общая реаниматология.2011; 7 (6): 59 — 65.
10. Лихванцев В.В., Мороз В.В., Гребенников О.А., Гороховатский Ю.И., Заржецкий Ю.В., Тимошин С.С., Левиков Д.И., Шайбакова В.Л.Ише-мическое и фармакологическое прекондиционирование.Общаяреаниматология.2012; 8 (1): 61—66.
11. Cleveland J.CJr., Meldrum D.R., Cain B.S., Banerjee A., Harken A.H.Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium.Circulation.1997; 96 (1): 29—32.
12. Klepzig H., Kober G., Matter C., Luus H., Schneider H., Boedeker K.H., Kiowski W., Amann F.W., Gruber D., Harris S., Burger W.Sulfonylureas and ischaemic preconditioning.Eur. Heart J.1999; 20 (6): 439—446.
13. Molojavyi A., Preckel B., Comfre T., Mullenheim J., Thamer V., Schlack W.Effects of ketamine and its isomers on ischemic preconditioning in the isolated rat heart.Anesthesiology.2001; 94 (4): 623—629.
14. Mullenheim J., Frassdorf J., Preckel B., Thamer V., Schlack W.Ketamine, but not S(+)-ketamine, blocks ischemic preconditioning in rabbit heartsin vivo. Anesthesiology.2001; 94 (4): 630—636.
15. Mullenheim J., Rulands R., Wietschorke T., Frassdorf J., Preckel B., Schlack W.Late preconditioning is blocked by racemic ketamine, but not by S(+)-Ketamine.Anesth. Analg.2001; 93 (2): 265—270.
16. Kozlowski R.Z., Ashford M.LJ.Barbiturates inhibit ATP-K+ channels and voltage-activated currents in CRI-G1 insulin-secreting cells.Br. J. Pharmacol1991; 103 (4): 2021—2029.
17. Tsutsumi Y., Oshita S., Kitahata H., Kuroda Y., Kawano T., Nakaya Y.Blockade of adenosine triphosphate-sensitive potassium channels by thiamylal in rat ventricular myocytes.Anesthesiology.2000; 92 (4): 1154—1159.
18. Mullenheim J., Molojavyi A., Preckel B., Thamer V., Schlack W.Thiopentone does not block ischemic preconditioning in the isolated rat heart.Can. J. Anesth.2001; 48 (8): 784—789.
19. Murphy P.G., Myers D.S., Davies M.J., Webster N.R., Jones J.G.The antioxidant potential of propofol (2,6—diisopropylphenol).Br. J. Anaesth.1992; 68 (6): 613—618.
20. Kokita N., Hara A.Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart.Anesthesiology.1996; 84 (1): 117—127.
21. Sztark F., Ichas F., Ouhabi R., Dabadie P., MazatJP.Effects of the anaesthetic propofol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential.FEBS Letters.1995; 368 (1): 101—104.
22. Kim J.M., Jang Y.H., Kim J.Morphine and remifentanil-induced cardio-protection: its experimental and clinical outcomes.Korean J. Anesthesiol.2011; 61 (5): 358—366.
23. EbelD., Schlack W., Comfrne T., PreckelB., Thamer V.Effect of propofol on reperfusion injury after regional ischaemia in the isolated rat heart.Br. J. Anaesth.1999; 83 (6): 903—908.
24. Xia Z., Huang Z., Ansley D.M.Large-dose propofol during cardiopul-monary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: acomparison with isoflurane.Anesth. Analg.2006; 103 (3): 527—532.
25. ШевченкоЮЛ., ГороховатскийЮ.И., АзизоваО.А., ГудымовичВ.Г.Севофлуран в кардиохирургии.Кардиология и сердечно-сосудистая хирургия.2009; 2 (2): 58—65.
26. Корпачев В.Г., Лысенков С.П., Тель Л.З.Моделирование клинической смерти и постреанимационной болезни у крыс.Патол. физиология и экперим. терапия.1982; 3: 78—80.
27. Лихванцев В.В., Гребенчиков ОА., Борисов К.Ю.Механизмы фармакологического прекондиционирования мозга и сравнительная эффективность препаратов — ингибиторов гликоген-синтетазы-кина-зы — 3-бета прямого и непрямого действия.Общая реаниматология.2012; 8 (6): 37—43.
28. Гребенчиков О.А., Мурачев А.С., Левиков Д.И., Селиванов Д.Д., Лих-ванцев В.В.Ингаляцоинная индукция на основе севофлурана у пожилых больных высокого риска в некардиальной хирургии.Общаяреаниматология.2011; 7 (3): 59—62.
29. Baines C.P., Pass J.M., Ping P.Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning.Basic. Res. Cardiol.2001; 96 (3): 207—218.
30. Strasser R.H., Braun-Dullaeus R., Walendzik H., Marquetant R.Alpha 1-receptor-independent activation of protein kinase C in acute myocar-dial ischemia. Mechanisms for sensitization of the adenylyl cyclase system.Circ. Res.1992; 70 (6): 1304—1312.
31. Kawamura S., Yoshida K., Miura T., Mizukami Y., Matsuzaki M.Ischemic preconditioning translocates PKC-delta and -epsilon, which mediate functional protection in isolated rat heart.Am. J. Physiol.1998; 275 (6 Pt 2): H2266—H2271.
32. Billman G.E.Role of ATP sensitive potassium channel in extracellular potassium accumulation and cardiac arrhythmias during myocardial ischaemia.Cardiovasc. Res.1994; 28 (6): 762—769.
33. Murata M., Akao M., O’Rourke B., Marban E.Mitochondrial ATP-sensi-tive potassium channels attenuate matrix Ca2+overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection.Circ. Res.2001; 89 (10): 891—898.
34. Wang L., Cherednichenko G., Hernandez L., Halow J., Camacho S.A., Figueredo V., Schaefer S.Preconditioning limits mitochondrial Ca(2+) during ischemia in rat hearts: role of K(ATP) channels.Am. J. Physiol. Heart Circ. Physiol.2001; 280 (5): H2321—H2328.
35. Zaugg M., Lucchinetti E., Spahn D.R., Pasch T., Schaub M.C.Volatile anesthetics mimic cardiac preconditioning by priming the activation of mitochondrial K(ATP) channels via multiple signaling pathways.Anesthesiology.2002; 97 (1): 4—14.
36. de Ruijter W., Musters RJ., Boer C., Stienen GJ., SimonidesW.S.,de Lange J.J.The cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K+ATPchannels, and the production of reactive oxygen species.Anesth. Analg.2003; 97 (5): 1370—1376.
37. Murry C.E., Richard V.J., Jennings R.B., Reimer K.A.Preconditioning with ischemia: is the protective effect mediated by free radical induced myocardial stunning?Circulation.1988; 78 (2): 77—84.
38. Chen W., Gabel S., Steenbergen C., Murphy E.A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat.Heart Circ. Res.1995; 77 (2): 424—429.
39. Forbes R.A., Steenbergen C., Murphy E.Diazoxide-induced cardiopro-tection requires signaling through a redox-sensitive mechanism.Circ. Res.2001; 88 (8): 802—809.
40. Griffiths E.J., Halestrap A.P.Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion.Biochem. J.1995; 307 (1): 93—98.
41. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott SJ.Glycogen synthase kinase-3b mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore.J. Clin. Invest.2004; 113 (11): 1535—1549.
42. Sato T., Sasaki N., O’Rourke B., Marban E.Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning?Circulation.2000; 102 (7): 800—805.
43. Tong H., Imahashi K., Steenbergen C., Murphy E.Phosphorylation of glycogen synthase kinase-3b during preconditioning through a phos-phatidylinositol-3—kinase-dependent pathway is cardioprotective.Circ. Res.2002; 90 (4): 377—379.
44. Wu Q.L., Shen T., Shao L.L., Ma H., Wang J.K.Ischemic postcondition-ing mediates cardioprotection via PI3K/GSK-3b/E-catenin signaling pathway in ischemic rat myocardium.Shock.2012; 38 (2): 165—169.
45. Onishi A., Miyamae M., Kaneda K., Kotani J., Figueredo V.M.Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.Eur. J. Pharmacol.2012; 675 (1—3): 40—46.
46. Green D.R., ReedJ.C.Mitochondria and apoptosis.Science.1998; 281 (5381): 1309—1312.
47. Bernardi P.The mitochondrial permeability transition pore: a mystery solved?Front Physiol.2013; 4: 95.
48. Siemen D., Ziemer M.What is the nature of the mitochondrial permeability transition pore and what is it not?IUBMBLife.2013; 65 (3): 255—262.
Review
For citations:
Borisov K.Yu., Moroz V.V., Grebenchikov O.A., Plotnikov E.Yu., Levikov D.I., Cherpakov R.A., Likhvantsev V.V. Effect of Propofol on Sevoflurane-Induced Myocardial Preconditioning in the Experiment . General Reanimatology. 2013;9(4):30. (In Russ.) https://doi.org/10.15360/1813-9779-2013-4-30
Views:
1422
Email this article 